Bullboard - Stock Discussion Forum ESSA Pharma Inc EPIX

Healthcare Biotechnology

ESSA Pharma Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing proprietary therapies for the treatment of patients with prostate cancer. Its lead candidate, Masofaniten (formerly EPI-7386), is an oral, small molecule that inhibits the N-terminal domain of the androgen receptor (AR). Masofaniten is in development in combination with antiandrogen... see more

Add To Watchlist

NDAQ:EPIX - Post Discussion

ESSA Pharma Inc > Bronstein, Gewirtz & Grossman, LLC Is Investigating ESSA Pha

View:

Post by whytestocks on Nov 04, 2024 12:31pm

Bronstein, Gewirtz & Grossman, LLC Is Investigating ESSA Pha

Breaking News: $EPIX Bronstein, Gewirtz & Grossman, LLC Is Investigating ESSA Pharma Inc. (EPIX) And Encourages Investors to ConnectNEW YORK CITY, NY / ACCESSWIRE / November 4, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ESSA Pharma Inc. ("ESSA" or "the Company") (NASDAQ:EPIX). Investors who purchased ESSA securities are encouraged to obtain additional informatio...EPIX - Bronstein, Gewirtz & Grossman, LLC Is Investigating ESSA Pharma Inc. (EPIX) And Encourages Investors to Connect